Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Coagulation Factor Ix Recombinant

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Alprolix

    02 6BeneFIX

    03 1Benefix

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Alprolix

    France
    arrow
    ChemOutsourcing
    Attending
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 553

    2021 Revenue in Millions : 456

    Growth (%) : 21

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Alprolix

    France
    arrow
    ChemOutsourcing
    Attending
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 583

    2022 Revenue in Millions : 553

    Growth (%) : 7

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Alprolix

    France
    arrow
    ChemOutsourcing
    Attending
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 322

    2017 Revenue in Millions : 0

    Growth (%) : NA

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2019 Revenue in Millions : 488

    2018 Revenue in Millions : 554

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2020 Revenue in Millions : 454

    2019 Revenue in Millions : 488

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2021 Revenue in Millions : 438

    2020 Revenue in Millions : 454

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2022 Revenue in Millions : 425

    2021 Revenue in Millions : 438

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Alprolix

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Alprolix

    Sweden
    arrow
    APGA Annual Conference
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 178

    2021 Revenue in Millions : 190

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 424

    2022 Revenue in Millions : 425

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Alprolix

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Alprolix

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Biogen

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 0

    2017 Revenue in Millions : 26

    Growth (%) : -100%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF